REG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - TAKEDA PHARMACEUTICAL

Takeda Pharmaceutical CoAnnouncement

13/09/2018 11:15

RNS Number : 7066A
Morgan Stanley
13 September 2018
 


 
FORM 8.5 (EPT/NON-RI)
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 



(a) Name of exempt principal trader:


Morgan Stanley MUFG Securities Co., Ltd.




(b) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical Company Limited




(c) Name of the party to the offer with which exempt principal trader is connected:


Shire plc




(d) Date position held/dealing undertaken:
     For an opening position disclosure, state the latest practicable date prior to the disclosure


12 SEPTEMBER 2018




(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?
     If it is a cash offer or possible cash offer, state "N/A"


YES - Shire plc



 
2.         POSITIONS OF THE EXEMPT PRINCIPAL TRADER                            
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 



 
Class of relevant security:


 
Ordinary




 
 


Interests


Short positions




Number


%


Number


%




(1) Relevant securities owned and/or controlled:


7,511,424


0.96


14,250,217


1.82




(2) Cash-settled derivatives:
 


13,378,218


1.71


5,901,681


0.75




(3) Stock-settled derivatives (including options) and agreements to purchase/sell:


0


0.00


0


0.00




 
     TOTAL:


20,889,642


2.67


20,151,898


2.57



 
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)
 



Class of relevant security in relation to which subscription right exists:


N/A




Details, including nature of the rights concerned and relevant percentages:


N/A



 
 
3.         DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales
 



Class of relevant security


 Purchases/sales


 Total   number of securities


 Highest price per unit paid/received


 Lowest price per unit paid/received




 Ordinary


 PURCHASES


 1,294,371


 4,601.3800 JPY


 4,532.0000 JPY




 Ordinary


 SALES


 1,056,242


 4,601.3800 JPY


 4,532.0000 JPY



 
 (b)       Cash-settled derivative transactions
 



Class of relevant security


 Product description
            e.g. CFD


 Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


 Number of reference securities


 Price per unit




Ordinary


CFD


LONG


3000


4567.8153 JPY




Ordinary


CFD


SHORT


5400


4568.4814 JPY




Ordinary


CFD


LONG


13800


4561.9855 JPY




Ordinary


CFD


SHORT


100


4574.0000 JPY




Ordinary


CFD


SHORT


250000


4600.0575 JPY




Ordinary


CFD


LONG


37700


4557.8992 JPY




Ordinary


CFD


SHORT


3200


4570.9375 JPY




Ordinary


CFD


SHORT


300


4600.0000 JPY




Ordinary


CFD


SHORT


2000


4539.1000 JPY




Ordinary


CFD


LONG


2000


4564.7500 JPY




Ordinary


CFD


SHORT


600


4600.0000 JPY




Ordinary


CFD


SHORT


2100


4600.0000 JPY




Ordinary


CFD


LONG


2100


4574.0000 JPY




Ordinary


CFD


SHORT


600


4600.0000 JPY




Ordinary


CFD


LONG


2000


4574.0000 JPY




Ordinary


CFD


SHORT


2000


4600.0000 JPY




Ordinary


CFD


SHORT


4100


4566.4502 JPY




Ordinary


CFD


LONG


48300


4555.2888 JPY




Ordinary


CFD


SHORT


9200


4558.6413 JPY




Ordinary


CFD


LONG


200


4583.5000 JPY




Ordinary


CFD


LONG


108000


4591.8148 JPY




Ordinary


CFD


LONG


500


4562.8000 JPY




Ordinary


CFD


SHORT


100


4571.0000 JPY




Ordinary


CFD


LONG


5300


4560.8679 JPY




Ordinary


CFD


LONG


600


4569.1666 JPY




Ordinary


CFD


SHORT


200


4600.0000 JPY




Ordinary


CFD


LONG


4500


4563.6444 JPY




Ordinary


CFD


SHORT


200


4561.0000 JPY




Ordinary


CFD


LONG


900


4600.0000 JPY




Ordinary


CFD


SHORT


1800


4584.7222 JPY




Ordinary


CFD


LONG


9300


4596.5698 JPY




Ordinary


CFD


SHORT


7400


4592.7909 JPY




Ordinary


CFD


SHORT


14600


4592.7909 JPY




Ordinary


CFD


LONG


68871


4589.1867 JPY




Ordinary


CFD


SHORT


236610


4570.4507 JPY




Ordinary


CFD


LONG


9800


4569.0510 JPY




Ordinary


CFD


SHORT


8600


4588.7511 JPY



 
 (c)       Stock-settled derivative transactions (including options)               
 
(i)         Writing, selling, purchasing or varying
 



Class of relevant security


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit




N/A


N/A


N/A


N/A


N/A


N/A


N/A


N/A



 
(ii)        Exercise
 



Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit




N/A


N/A


N/A


N/A


N/A



 
(d)        Other dealings (including subscribing for new securities)
 



Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable)




N/A


N/A


N/A


N/A



 
 
4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
None
 



 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
None
 



 
(c)        Attachments
 



Is a Supplemental Form 8 (Open Positions) attached?


NO



 
 



Date of disclosure:


13 SEPTEMBER 2018




Contact name:


Craig Horsley




Telephone number:


+44(141) 245 7736



 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEOEAENDFFEPEFF